13F Data
13F filer · CIK 1627608

Monashee Investment Management LLC

Boston, MA · filing since Q1 2015 · last filing Nov 6, 2026
Reported value
$33.4M
$-26.2M vs prior
Positions
16
New / sold out
13 / 20
Added / reduced
0 / 3
Turnover
57.2%
buys $26.6M · sells $50.9M
Top-10 weight
88.4%

Biggest buys vs Q2 2026

ChangeSecurityShares changeChange %Est. trade value
NewAXON ENTERPRISE INC+5,000,000–+$4.9M
NewIMMIX BIOPHARMA INC+450,000–+$4.7M
NewSYSCO CORP+55,000–+$4.3M
NewNEWCLEO PLC+400,000–+$3.1M
NewENBRIDGE INC+50,000–+$2.3M
NewVIKING THERAPEUTICS INC+1,500,000–+$1.5M
NewBLOSSOMHILL THERAPEUTICS INC+80,000–+$1.5M
NewELECTRA THERAPEUTICS INC+100,000–+$1.1M
NewYARROW BIOSCIENCE INC+40,000–+$900.8K
NewAVEANNA HEALTHCARE HLDGS INC+50,000–+$620.5K
3 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q2 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outALPHABET INC-100,000-100.0%$-5.1M
Sold outALPHABET INC-100,000-100.0%$-5.0M
Sold outDIGITAL RLTY TR INC-25,000-100.0%$-4.5M
Sold outSPYRE THERAPEUTICS INC-50,000-100.0%$-4.4M
Sold outTANGO THERAPEUTICS INC-100,000-100.0%$-3.1M
Sold outCELCUITY INC-2,500,000-100.0%$-2.8M
Sold outSUPER MICRO COMPUTER INC-50,000-100.0%$-2.6M
Sold outLEGEND BIOTECH CORP-85,385-100.0%$-2.5M
Sold outALPHABET INC-6,000-100.0%$-2.1M
Sold outALPHABET INC-6,000-100.0%$-2.1M
13 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q1 2015: $160.6MQ2 2015: $212.0MQ3 2015: $14.5MQ4 2015: $50.2MQ1 2016: $54.7MQ2 2016: $63.5MQ3 2016: $284.3MQ4 2016: $205.4MQ1 2017: $249.0MQ2 2017: $236.6MQ3 2017: $264.3MQ4 2017: $235.9MQ1 2018: $362.2MQ2 2018: $525.3MQ3 2018: $472.2MQ4 2018: $147.7MQ1 2019: $434.7MQ2 2019: $386.2MQ3 2019: $219.4MQ4 2019: $107.4MQ1 2020: $186.6MQ2 2020: $668.9MQ3 2020: $464.4MQ4 2020: $757.4MQ1 2021: $650.2MQ2 2021: $836.0MQ3 2021: $541.5MQ4 2021: $404.6MQ1 2022: $345.3MQ2 2022: $274.7MQ3 2022: $269.6MQ4 2022: $232.3MQ1 2023: $362.2MQ2 2023: $418.9MQ3 2023: $239.4MQ4 2023: $566.5MQ1 2024: $845.3MQ2 2024: $773.4MQ3 2024: $923.5MQ4 2024: $729.2MQ1 2025: $845.1MQ2 2025: $275.9MQ3 2025: $200.5MQ4 2025: $177.5MQ1 2026: $183.8MQ2 2026: $59.6MQ3 2026: $33.4M
Q1 2015Q3 2026

Holdings · Q3 2026

#SecuritySharesValueWeight
1AXON ENTERPRISE INCNOTE 9/15,000,000$4.9M14.80%
2IMMIX BIOPHARMA INCCOM450,000$4.7M14.02%
3SYSCO CORPCOM55,000$4.3M12.84%
4NEWCLEO PLCORDINARY SHARES400,000$3.1M9.40%
5ADT INC DELCOM500,000$3.0M9.10%
6SOLID BIOSCIENCES INCCOM NEW410,000$3.0M8.87%
7ENBRIDGE INCCOM50,000$2.3M6.96%
8VIKING THERAPEUTICS INCNOTE 2.000%10/11,500,000$1.5M4.60%
9BLOSSOMHILL THERAPEUTICS INCCOM80,000$1.5M4.46%
10ELECTRA THERAPEUTICS INCCOM100,000$1.1M3.37%
6 more rows. Subscribe for $29/month to see every row, download the data and use the API.